2nd Quarter - Report

AEGIS LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Period 2nd Quarter 2026 Filed Jul 2, 2026 Signed by Beth Anne Cole

Official filing
Firm
AEGIS LLC
Client
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Pharmacy Benefit Manager (PBM) issues and reform. 340B. IRA implementation. H.R.1492: Ensuring Pathways to Innovative Cures (EPIC) Act. Drug pricing. Most-Favored Nation (MFN) International reference pricing. H.R.5378 - Lower Costs, More Transparency Act. H.R.5376 - Share the Savings with Seniors Act. H.R.6283/S.1542 - DRUG Act. H.R.830 - HELP Copays Act.

LobbyistCovered position, as disclosed
ANNE ELIZABETH ESPOSITO Health Policy Coordinator, Energy and Commerce Committee; Health Policy Advisor, Health Subcommittee (Chairman Bilirakis)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6283 (119th), S. 1542 (119th), H.R. 5376 (119th), H.R. 830 (119th), H.R. 1492 (119th), H.R. 5378 (119th)

Health Issues HCR

General health care issues.

LobbyistCovered position, as disclosed
ANNE ELIZABETH ESPOSITO —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.